3-Ethoxy-4-methoxybenzaldehyde

We are 3-Ethoxy-4-methoxybenzaldehyde CAS:1131-52-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 1131-52-8
Product Name: 3-Ethoxy-4-methoxybenzaldehyde
Other Name:
3-Ethoxy-4-methoxybenzaldehyde
3-Aethoxy-4-methoxy-benzaldehyd
3-Ethoxy-p-anisaldehyde
4-methoxy-3-ethoxybenzaldehyde
 
Density: 1.1±0.1 g/cm3
Boiling Point: 289.4±20.0 °C at 760 mmHg
Melting Point: 51 °C
Molecular Formula: C10H12O3
Molecular Weight: 180.201
Flash Point: 119.6±8.2 °C
Exact Mass: 180.078644
PSA: 35.53000
LogP: 2.14
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.528
 
Specification
Appearance: White to yellow crystals
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Apremilast CAS: 608141-41-9.
Be used as pharmaceutical intermediate. Mainly be used in the synthesis of drugs (isovanillin) and the synthesis of aposite intermediates.
3-Ethoxy-p-anisaldehyde is used in the preparation of PDE4 inhibitors. Also used in the preparation of berberine analogues, as LDL-receptor upregulators.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Ethoxy-4-methoxybenzaldehyde


Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine CAS:83255-86-1 This includes chemical APIs.4-Bromo-2-fluorobenzyl bromide CAS:76283-09-5 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.dimethicone macromolecule CAS:9006-65-9;9016-00-6;63148-62-9 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.

Related Products
Product Name
Methyl glutarate View Details
4-Bromo-2-methylpyridine View Details
Vinylmethyldimethoxysilane View Details
4-Methylphenylboronic Acid manufacturer 3-Fluoro-2-methylbenzaldehyde manufacturer Pentachloropyridine manufacturer ADP manufacturer 2-Amino-6-methylphenol manufacturer